Clinical Trials Browser

Blood Specimen Collection × Genitourinary × Clear all

NCT06492122 2026-05-26

ProTACT

Phase 1 Recruiting

Metastatic Castration-resistant Prostate Cancer

NCT06195150 2026-05-11

ITHORinVHL

Active not recruiting

Carcinoma, Renal Cell, von Hippel-Lindau Disease

NCT07555600 2026-04-29

E-FACTOR

Phase NA Not yet recruiting

BreastGastrointestinalGenitourinaryGynecologic

Breast Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms

NCT06147414 2026-04-23

DANNIgene

CNSClassical hematologyGenitourinary

Hydrocephalus, X-linked, Neurofibromatosis-Noonan syndrome, Anemia, Sickle Cell, Hemophilia B, Cystic Fibrosis, Fragile X Syndrome, Hemophilia A, Huntington Disease, Myotonic Dystrophy, Polycystic Kidney, Autosomal Recessive, Neurofibromatoses, Muscular Dystrophy, Duchenne

NCT03846128 2026-04-14

BIOSUNTOX

Kidney Neoplasms

NCT02087852 2026-04-09

Kidney Cancer DNA Registry

Kidney Neoplasms

NCT06020651 2026-04-08

VICKI

Phase NA Completed

Urinary Bladder Neoplasms, Carcinoma, Renal Cell, Neoplasms, Vascular Diseases, Atherosclerosis

NCT02822404 2026-04-01

CysPed

Phase NA Completed

Kidney Diseases

NCT07054346 2026-04-01

LUTACT

Phase 1 Recruiting

Disease, Prostatic Neoplasms

NCT04167969 2026-03-27

The Use of Nanoparticles to Guide the Surgical Treatment of Prostate Cancer

Phase 1 Recruiting

Prostatic Neoplasms

NCT06435546 2026-03-27

AdOTAC

Phase NA Completed

BreastGenitourinary

Breast Neoplasms, Prostatic Neoplasms

NCT03185039 2026-03-19

Predictive Impact of MMP2 and MMP9 Levels for Patients With Metastatic Kidney Cancer Treated With Anti-angiogenic Agents

Phase NA Active not recruiting

Kidney Neoplasms

NCT05435495 2026-03-18

Mechanisms of Resistance to PSMA Radioligand Therapy

Prostatic Neoplasms

NCT06349642 2026-03-12

ELEPHAS-04

DermatologicGastrointestinalGenitourinaryGynecologicSarcomaThoracic

Clear-cell metastatic renal cell carcinoma, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinosarcoma, Uterine Cervical Neoplasms, Esophageal Neoplasms, Carcinoma, Hepatocellular, Neoplasm Metastasis, Skin Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms

NCT07463508 2026-03-11

TG-BIL

Phase NA Recruiting

Testicular Neoplasms

NCT06960798 2026-03-02

Characterizing the Genomic Landscape of Prostate Cancer in Native American Populations (NAT-Geno)

Prostatic Neoplasms

NCT04662996 2026-02-12

MiR_CPMRC

Phase NA Completed

Prostatic Neoplasms, Disease Resistance

NCT07406646 2026-02-12

EXO-RENAL1

Phase NA Completed

Carcinoma, Renal Cell

NCT05890781 2026-02-09

IMMUNEORGANOID

Phase NA Recruiting

CNSGenitourinarySarcoma

Brain Neoplasms, Carcinoma, Renal Cell, Neuroblastoma, Sarcoma

NCT06674811 2026-01-26

BRICCS

CNSGenitourinarySarcoma

Neoplasms, Wilms Tumor, Neuroblastoma, Sarcoma

NCT06600802 2025-12-31

PSMA-PRED

Phase NA Recruiting

Castration-resistant Metastatic Prostate Cancer

NCT02657863 2025-12-23

Cancer DNA Detection in Blood and Urine

Prostatic Neoplasms

NCT02869282 2025-09-17

CHEMOPROST

Prostatic Neoplasms

NCT05141383 2025-09-08

HOPE

Phase NA Completed

Disease, Prostatic Neoplasms

NCT05011188 2025-08-27

FOR46 in Combination With Enzalutamide in Patients With Metastatic Castration Resistant Prostate Cancer

Phase 1/2 Active not recruiting

Prostatic Neoplasms

NCT05151341 2025-07-24

URODX-FGFR3

Phase NA Completed

Urinary Bladder Neoplasms, Disease, Neoplasms

NCT06942104 2025-07-18

Imaging of Solid Tumors Using 18F-TRX

Phase 1 Recruiting

CNSGenitourinary

Clear-cell metastatic renal cell carcinoma, Carcinoma, Renal Cell, Glioma, Neoplasm Metastasis, Prostatic Neoplasms

NCT06896162 2025-07-11

PROGRESS

Phase NA Recruiting

BreastGastrointestinalGenitourinaryThoracic

Urinary Bladder Neoplasms, Breast Neoplasms, Lung Neoplasms, Neoplasm Metastasis, Colorectal Neoplasms

NCT04581109 2025-07-10

EPIDROP

Phase NA Recruiting

Neoplastic Cells, Circulating, Prostatic Neoplasms

NCT06904313 2025-06-04

Ultralow Dose PET Imaging for PSMA Expression

Phase 2 Recruiting

Prostatic Neoplasms

NCT05062707 2025-05-13

Early Ageing During Therapy in AYA Cancer Patients

BreastGenitourinaryGynecologicLymphoidOther hematologic neoplasmSarcoma

Breast Neoplasms, Uterine Cervical Neoplasms, Hodgkin Disease, Leukemia, Neoplasms, Sarcoma, Ewing, Osteosarcoma, Testicular Neoplasms

NCT01437488 2025-05-04

Cabazitaxel in Patients With Urothelial Carcinoma Who Have Disease Progression Following Platinum-Based Chemotherapy

Phase 2 Completed

14 enrolled 12 charts

Carcinoma, Transitional Cell

NCT05819827 2025-04-27

Associations Between Chemotherapy-Induced Nausea in Patients With Genitourinary, Sarcoma or Melanoma Cancers and Changes in Gut Microbiome: Potential for Precision Therapeutics

DermatologicGenitourinarySarcoma

Urinary Bladder Neoplasms, Melanoma, Prostatic Neoplasms, Sarcoma, Testicular Neoplasms

NCT06827639 2025-02-14

FUTURE

Not yet recruiting

BreastGastrointestinalGenitourinaryHead & NeckLymphoidOther hematologic neoplasmThoracic

Breast Neoplasms, Head and Neck Neoplasms, Leukemia, Liver Neoplasms, Lung Neoplasms, Lymphoma, Stomach Neoplasms, Urologic Neoplasms

NCT04823923 2025-02-12

IREKI

Phase NA Recruiting

Kidney Neoplasms, Renal Insufficiency

NCT06509919 2024-12-27

Application of a Novel Biomarker Based on Plasma cfDNA Assay in the Early Diagnosis of Prostate Cancer

Prostatic Neoplasms

NCT04883827 2024-10-22

Disease Burden and Biology Using Tumor Cell Free DNA in Metastatic Kidney Cancer

Carcinoma, Renal Cell

NCT03558048 2024-04-24

The Effect of IBD Flares on Serum PSA

Prostatic Neoplasms, Inflammatory Bowel Diseases

NCT06260410 2024-04-22

LUTRAC

Prostatic Neoplasms

NCT05415787 2024-03-01

PROMECI

Prostatic Neoplasms

NCT04732156 2024-02-28

CHANGE

Phase NA Recruiting

Prostatic Neoplasms

NCT06194669 2024-01-10

SoMuKT

Carcinoma, Renal Cell, von Hippel-Lindau Disease

NCT03871816 2023-12-11

A Study to Determine Frequency of DNA-repair Defects in Men With Metastatic Prostate Cancer

14,532 enrolled

Prostatic Neoplasms

NCT06116851 2023-11-03

PROMIC

Prostatic Hyperplasia, Prostatic Neoplasms

NCT02070575 2023-10-23

Evaluation of Molecular Forms of PSA and Human Kallikrein 2 in a Cohort of Patients With Locally Resected Prostate Cancer But Biochemical Recurrence

Prostatic Neoplasms

NCT05437679 2023-09-05

CHARTER

Neoplastic Cells, Circulating, Prostatic Neoplasms

NCT03381326 2023-06-02

IRSTB030

Neoplastic Cells, Circulating, Neoplasm Metastasis, Prostatic Neoplasms

NCT05285579 2023-04-19

ANGIOCOR

Carcinoma, Renal Cell, Kidney Neoplasms

NCT04324983 2023-04-12

BioPoP

Phase NA Completed

Prostate Cancer Recurrent

NCT04487457 2023-04-06

CINECI

GenitourinaryThoracic

Urinary Bladder Neoplasms, Carcinoma, Non-Small-Cell Lung